This inventor holds 4 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignee: G2gbio, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Eunyoung Seol: Innovator in Pharmaceutical Technologies
Introduction
Eunyoung Seol is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release formulations. With a total of 4 patents to his name, his work focuses on innovative solutions for various health conditions.
Latest Patents
One of Eunyoung Seol's latest patents is a pharmaceutical composition comprising sustained-release microspheres that include a GLP-1 analogue or a pharmaceutically acceptable salt thereof. This invention is particularly useful for the prevention or treatment of diabetes, preservation of beta-cell function, high blood pressure, hyperlipidemia, obesity, non-alcoholic steatohepatitis, and neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. The sustained-release microsphere formulation effectively inhibits fatal side effects by preventing the initial burst of the drug, allowing for a higher drug content relative to particle size. This innovation minimizes patient pain and inflammatory reactions during administration.
Another notable patent is a sustained-release injection comprising deslorelin, along with its preparation method. This formulation utilizes biodegradable polymer microspheres containing deslorelin as the active ingredient. The sustained-release microsphere injection allows for effective drug concentration maintenance for up to six months with a single administration, avoiding rapid temporary release into the bloodstream of an animal.
Career Highlights
Eunyoung Seol is currently associated with G2gbio, Inc., where he continues to advance his research and development efforts in pharmaceutical technologies. His work has garnered attention for its potential to improve patient outcomes through innovative drug delivery systems.
Collaborations
Eunyoung collaborates with talented individuals in his field, including Heeyong Lee and Yongha Na. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical innovations.
Conclusion
Eunyoung Seol is a dedicated inventor whose work in pharmaceutical formulations is paving the way for improved treatment options. His innovative patents reflect a commitment to enhancing patient care and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile